Jacob Vincent Micallef - 01 May 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Chief Scientific Officer
Signature: /s/ Jacob Vincent Micallef
Issuer symbol: VNRX
Transactions as of: 01 May 2025
Net transactions value: -$8,931
Form type: 4
Filing time: 05 May 2025, 16:05:08 UTC
Previous filing: 31 Jan 2025
Next filing: 19 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Micallef Jacob Vincent	Chief Scientific Officer	1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON	/s/ Jacob Vincent Micallef	05 May 2025	0001651671

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Tax liability	$8,931	-18,319	-4.6%	$0.4875	376,033	01 May 2025	Direct	F1
holding	VNRX	Common Stock						55,000	01 May 2025	By Spouse
holding	VNRX	Common Stock						38,113	01 May 2025	By Borlaug Limited	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 40,709 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
F2	The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.

Content

Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 40,709 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.